News
Diabetic retinopathy involves the changes for the blood vessels in your eye due to the high sugars that are in your body from diabetes, if you're a diabetic and you notice changes to your vision ...
MAs only without other diabetic lesions 31 MAs and one or more of the following: retinal hemorrhage (but a total of hemorrhages and MAs less than those in standard photograph 2A), hard exudates ...
7d
Clinical Trials Arena on MSNFirst subject dosed in Vantage’s Phase II trial for diabetic retinopathyVantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat ...
Below a specific threshold, FCP exerts a protective effect, but above that threshold the protective effect becomes uncertain.
16d
The Print on MSNSilent threat of diabetic retinopathy: Eye doctors bat for advanced treatments to be part of AB-PMJAYDiabetic retinopathy affects 30 lakh Indians and can lead to vision loss. Advanced therapies include costly injections currently not covered under Centre’s healthcare scheme.
During a median follow-up period of 12.3 years, 4399 cases of diabetic microvascular complications were recorded, including 2084 cases of nephropathy, 2401 cases of retinopathy, and 831 cases of ...
Diabetic retinopathy (DR), a serious eye condition caused by damage to the blood vessels in the retina—the light-sensitive tissue at the back of the eye—is a major public health concern in India.
Diabetic retinopathy affects more than 100 million people worldwide and is one of the leading causes of blindness among working-age adults. Without timely intervention, NPDR can progress to more ...
Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat non-proliferative diabetic retinopathy (NPDR). The multi-centre, placebo-controlled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results